首页> 外文期刊>The Turkish journal of pediatrics >Thrombotic thrombocytopenic purpura as a rare cause of anemia with thrombocytopenia in childhood: report of 2 cases
【24h】

Thrombotic thrombocytopenic purpura as a rare cause of anemia with thrombocytopenia in childhood: report of 2 cases

机译:血栓形成血小板减少紫癜作为儿童血小板血症血栓症的罕见原因:2例报告

获取原文
获取原文并翻译 | 示例
       

摘要

Thrombotic thrombocytopenic purpura (TTP) is a rare multisystem disorder characterized by single or recurrent episodes of thrombocytopenia, microangiopathic hemolytic anemia and widespread microvascular thrombosis, which causes significant morbidity and mortality unless promptly recognized and treated. The underlying pathogenesis is a defect in von Willebrand factor (vWF) cleaving protease, called "A Disintegrin and Metalloproteinase with Thrombospondin Type 1 Repeats 13 (ADAMTS-13)". There are 2 forms: congenital TTP (ADAMTS-13 gene mutations) and acquired TTP (autoantibodies and ADAMTS-13 deficiency). We presented two patients who initially presented with thrombotic microangiopathy and were later diagnosed with TTP upon demonstration of the deficiency in ADAMTS-13 activity.
机译:血栓性血小板减少性紫癜(TTP)是一种罕见的多系统疾病,其特征是血小板减少症、微血管病性溶血性贫血和广泛的微血管血栓形成的单一或反复发作,除非及时识别和治疗,否则会导致显著的发病率和死亡率。潜在的发病机制是血管性血友病因子(vWF)裂解蛋白酶的缺陷,称为“具有血栓反应蛋白1型重复序列13(ADAMTS-13)的去整合素和金属蛋白酶”。有两种形式:先天性TTP(ADAMTS-13基因突变)和后天性TTP(自身抗体和ADAMTS-13缺陷)。我们介绍了两名患者,他们最初表现为血栓性微血管病,后来在ADAMTS-13活性缺乏的情况下被诊断为TTP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号